SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
CRY Analysis & Videos »
CRY: Bull or Bear?
Long on CRY since 5.30
CRY
|
|
|
-24.65%
in
89 days
I bought CRY on Aug 11. I posted this on my blog on Aug 10: I have been looking for an undervalued stock based on EPS and had it down to just a handful of possibilities. I tried to buy CRY last week when it hit 5.00 but ETRADE wouldn't let me purchase for some reason. I moved the money over to Ameritrade and was able to purchase CRY today for about 5.30 a share. Based on market stabilization and the profitability of this company, I expect it to fully go above 10 a share by Feb 09. Just wanted to give you all a heads up if you are looking for a value stock in the healthcare industry. A...
|
Regenerative Medicine: The Next Frontier for Big Pharma
CRY
|
|
|
-39.86%
in
368 days
<> <> An article last week at the WSJ Health Blog outlined plans by Pfizer (PFE) to begin putting its billions of dollars in cash to use in the emerging field of regenerative medicine and stem cell therapies. Also, an article on Bloomberg identifies GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Novartis (NVS), and Roche (RHHBY) as other healthcare giants as active in regenerative medicine through investments and partnerships. The move by these healthcare mega-caps comes at a time when credit >>...
|
Cosmetic & Reconstructive Medicine Companies Outpace the Healthcare Sector
CRY
|
|
|
-25.34%
in
16 days
(closed on 11/17/08)
<> <> The accompanying table presents the statistics and seven highest rated companies from the ETFI Global Cosmetic and Reconstructive Medicine [CRM] Index, which includes companies with market caps over $100M engaged in prescription skin care treatments, weight loss, cosmetic medicine, regenerative medicine, orthopedic repair, and joint replacements. Over the past year, the CRM Index fared better than the Healthcare Sector SPDR (XLV) and the S&P 500 SPDR (SPY) for the top 30 rated companies a>>...
|
CryoLife Positives Accounted For
CRY
-45.15%
in
497 days
At this stage, we believe the majority of the positives that impacted growth expectations are priced in the stock. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the ef...
|
People Bullish on CRY
People Bearish on CRY
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
More Resources
|